Document and Entity Information Entity Addresses [Table] Entity Addresses [Line Items] Document Type Document Quarterly Report Document Period End Date Document Transition Report Entity File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Shell Company Entity Shell Company Entity Common Stock, Shares Outstanding Entity Central Index Key Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag CONDENSED CONSOLIDATED BALANCE SHEETS Assets [Abstract] ASSETS Assets, Current [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Cash and cash equivalents Prepaid Expense, Current Prepaid expenses and deposits Other Receivables, Net, Current Other receivables Assets, Current Total current assets Assets Total assets Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities, Current [Abstract] Current liabilities: Accounts Payable and Accrued Liabilities, Current Accounts payable and accrued liabilities Due to Related Parties, Current Related party payable Other Liability, Current, Related Party, Type [Extensible Enumeration] Liabilities, Current Total current liabilities Liabilities Total liabilities Stockholders' Equity Attributable to Parent [Abstract] Stockholders' equity: Preferred Stock, Value, Issued Preferred stock, $0.001 par value, 5 million shares authorized, 0 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively Common Stock, Value, Issued Common stock, $0.001 par value, 30 million shares authorized, 8.9 million shares issued and outstanding as of September 30, 2024 and December 31, 2023 (see Note 9) Additional Paid in Capital Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Stockholders' Equity Attributable to Parent Ending Balance Beginning Balance Total stockholders' equity Liabilities and Equity Total liabilities and stockholders' equity Statement [Table] Statistical Measurement [Axis] Statistical Measurement [Domain] Minimum [Member] Minimum Maximum [Member] Maximum Statements Statement Preferred Stock, Par or Stated Value Per Share Preferred stock par value (in $ per share) Preferred Stock, Shares Authorized Preferred stock authorized (in shares) Preferred Stock, Shares Issued Preferred stock issued Preferred Stock, Shares Outstanding Preferred stock outstanding Common Stock, Par or Stated Value Per Share Common stock par value (in $ per share) Common Stock, Shares Authorized Common stock authorized (in shares) Common Stock, Shares, Issued Common stock issued Common Stock, Shares, Outstanding Common stock outstanding CONSOLIDATED STATEMENTS OF OPERATIONS Product and Service [Axis] Product and Service [Domain] Grant [Member] Grant income Revenues [Abstract] Revenues: Revenue from Contract with Customer, Including Assessed Tax Revenue recognized Total revenues Costs and Expenses [Abstract] Operating expenses: Research and Development Expense Research and development General and Administrative Expense General and administrative Operating Expenses Total operating expenses Operating Income (Loss) Loss from operations Nonoperating Income (Expense) [Abstract] Other income (expenses): Investment Income, Interest Interest income Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Loss from continuing operations Loss from continuing operations No definition available. Discontinued Operation, Income (Loss) from Discontinued Operation [Abstract] Discontinued operations: Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax Loss from discontinued operations Loss from discontinued operations, net of tax Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax Gain on disposal of discontinued operations before income taxes Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Income from discontinued operations Income from discontinued operations Less: gain from discontinued operations, net of tax Net loss Net loss Earnings Per Share [Abstract] Net earnings (loss) per share: Net (loss) earnings per share: Income (Loss) from Continuing Operations, Per Basic Share Loss from continuing operations, basic (in dollars per share) Income (Loss) from Continuing Operations, Per Diluted Share Loss from continuing operations, diluted (in dollars per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share Income from discontinued operations, basic (in dollars per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share Income from discontinued operations, diluted (in dollars per share) Earnings Per Share, Basic Net loss per share, basic (in dollars per share) Earnings Per Share, Diluted Net loss per share, diluted (in dollars per share) Earnings Per Share, Basic, Other Disclosure [Abstract] Weighted average number of common shares outstanding: Weighted Average Number of Shares Outstanding, Basic Weighted average number of common shares outstanding, basic (in shares) Weighted average common shares outstanding, basic Weighted Average Number of Shares Outstanding, Diluted Weighted average number of common shares outstanding, diluted (in shares) Weighted average common shares outstanding, diluted CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Equity Components [Axis] Equity Component [Domain] Common Stock [Member] Common Stock Additional Paid-in Capital [Member] Additional Paid-in Capital Retained Earnings [Member] Accumulated Deficit Shares, Issued Ending Balance, Shares Beginning Balance, Shares Stock Issued During Period, Value, New Issues Shares purchased pursuant to ATM agreement Aggregate proceeds from shares issued under the purchase agreement Stock Issued During Period, Shares, New Issues Shares purchased pursuant to ATM agreement (in shares) Number of shares issued (in shares) It represents value of common stock as commitment fee for future financing. Issuance Of Common Stock , Value, As Commitment Fee For Future Financing Issuance of common stock as commitment fee for future financing It represents number of common stock issued as commitment fee for future financing. Issuance Of Common Stock, Shares, As Commitment Fee For Future Financing Issuance of common stock as commitment fee for future financing (in shares) Stock Issued During Period, Value, Stock Options Exercised Issuance of common stock from exercise of stock options Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Number of Shares, Exercised Issuance of common stock from exercise of stock options (in shares) Issuance of common stock from exercise of stock options (in shares) Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Stock-based compensation Reduction in the number of shares during the period as a result of a fractional shares adjustment due to reverse split. Stock Issued During Period, Shares, Fractional Shares Adjustment Due to Reverse Split Fractional shares adjustment due to reverse split CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Net Cash Provided by (Used in) Operating Activities [Abstract] Cash Flows from Operating Activities: Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Net loss from continuing operations Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Reconciliation of net loss to net cash used in operating activities: Share-Based Payment Arrangement, Noncash Expense Stock-based compensation Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Prepaid Expense Prepaid expenses and deposits Increase (Decrease) in Accrued Interest Receivable, Net Other receivables Increase (Decrease) in Due to Related Parties, Current Related party payable Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable and accrued expenses Increase (Decrease) in Deferred Revenue Deferred revenue Net Cash Provided by (Used in) Operating Activities, Continuing Operations Net cash used in operating activities - continuing operations Cash Provided by (Used in) Operating Activities, Discontinued Operations Net cash used in operating activities - discontinued operations Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] Cash Flows from Investing Activities: Cash Provided by (Used in) Investing Activities, Discontinued Operations Net cash provided by investing activities - discontinued operations Net cash provided by investing activities Net Cash Provided by (Used in) Investing Activities Net cash provided by investing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Cash Flows from Financing Activities: Proceeds from Issuance of Common Stock Proceeds from Issuance of Common Stock Proceeds from issuance of common stock, net Proceeds from Stock Options Exercised Proceeds from stock options exercise Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Net (decrease) increase in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Cash and cash equivalents at end of the period Cash and cash equivalents at beginning of the period NATURE OF OPERATIONS Nature of Operations [Text Block] NATURE OF OPERATIONS n/a BASIS OF PRESENTATION Basis of Accounting [Text Block] BASIS OF PRESENTATION n/a LIQUIDITY AND FINANCIAL CONDITION Liquidity Financial Condition And Going Concern Text Block Liquidity Financial Condition And Going Concern [Text Block] LIQUIDITY AND FINANCIAL CONDITION SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] SIGNIFICANT ACCOUNTING POLICIES NET LOSS PER SHARE Noncontrolling Interest Disclosure [Text Block] NET LOSS PER SHARE OTHER RECEIVABLE Loans, Notes, Trade and Other Receivables Disclosure [Text Block] OTHER RECEIVABLE DISCONTINUED OPERATIONS Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] DISCONTINUED OPERATIONS ACCOUNTS PAYABLE, ACCRUED LIABILITIES AND RELATED PARTY PAYABLE Accounts Payable and Accrued Liabilities Disclosure [Text Block] ACCOUNTS PAYABLE, ACCRUED LIABILITIES AND RELATED PARTY PAYABLE STOCKHOLDERS' EQUITY Stockholders' Equity Note Disclosure [Text Block] STOCKHOLDERS' EQUITY STOCK-BASED COMPENSATION Disclosure of Compensation Related Costs, Share-based Payments [Text Block] STOCK-BASED COMPENSATION GRANT INCOME Revenue from Contract with Customer [Text Block] GRANT INCOME LEGAL PROCEEDINGS Legal Matters and Contingencies [Text Block] LEGAL PROCEEDINGS RELATED PARTY EXPENSES Related Party Transactions Disclosure [Text Block] RELATED PARTY EXPENSES SUBSEQUENT EVENTS Subsequent Events [Text Block] SUBSEQUENT EVENTS Consolidation, Policy [Policy Text Block] Principles of Consolidation Use of Estimates, Policy [Policy Text Block] Use of Estimates Cash and Cash Equivalents, Policy [Policy Text Block] Cash, Cash Equivalents and Credit Risk Discontinued Operations, Policy [Policy Text Block] Discontinued Operations Disclosure of accounting policy for recently issued accounting standards not yet adopted. Recently Issued Accounting Standards Not yet Adopted [Policy Text Block] Recently Issued Accounting Standards Not Yet Adopted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of computation of net loss per share Tabular disclosure of net loss per share. Net Loss Per Share [Table Text Block] Schedule of anti-dilutive securities Disposal Groups, Including Discontinued Operations [Table Text Block] Schedule of income statement information and summary of cash flows for discontinued operations Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Schedule of accounts payable, accrued liabilities and related party payable This table lists the stock-based compensation. Stock-Based Compensation [Table] Line items represent stock-based compensation. Stock-Based Compensation [Line Items] STOCK-BASED COMPENSATION Share-based Payment Arrangement, Activity [Table Text Block] Schedule of the company's stock option activity Tabular disclosure of stock based compensation expenses recorded. Stock based Compensation Expenses [Table Text Block] Schedule of stock-based compensation expenses Schedule of Related Party Transactions [Table Text Block] Schedule of related party transaction expenses Disclosure of information about organization, consolidation and presentation of financial statements. Organization, Consolidation and Presentation of Financial Statements Type of Arrangement and Non-arrangement Transactions [Axis] Arrangements and Non-arrangement Transactions [Domain] Represents the information pertaining to Cell Ready Agreement. Cell Ready Agreement [Member] Cell Ready Purchase Agreement Disposal Group Classification [Axis] Disposal Group Classification [Domain] Discontinued Operations, Disposed of by Sale [Member] Disposed by sale Discontinued Operations, Disposed of by Sale Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Organization, Consolidation and Presentation of Financial Statements [Line Items] NATURE OF OPERATIONS Stockholders' Equity, Reverse Stock Split Reverse stock split Disposal Group, Including Discontinued Operation, Consideration Consideration for purchased assets Consideration for purchased assets The number of employees extended for employment. Offers Employment to Number of Employees Number of former employees offered employment Severance Costs Severance and termination-related costs Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed. Financial Condition Going Concern And Management Plans [Table] Represents the information pertaining to controlled equity offering sales agreement. Controlled Equity Offering Sales Agreement [Member] ATM Agreement This member stands for binding services agreement. Binding Services Agreement [Member] Binding Services Agreement Counterparty Name [Axis] Counterparty Name [Domain] Represents the information pertaining to Cantor Fitzgerald & Co and RBC Capital Markets, LLC. Cantor Fitzgerald Co. And Rbc Capital Markets Llc [Member] Sales Agents Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent event Related Party [Axis] Related Party [Domain] The information pertaining to Lincoln Park. Lincoln Park [Member] Lincoln Park This member represents information pertaining to National Institutes of Health Small Business Innovation Research. National Institutes of Health Small Business Innovation Research [Member] SBIR grant Represents information pertaining to grants from National Institutes of Health-National Cancer Institute. National Institutes of Health National Cancer Institute Grant [Member] National Institutes of Health National -Cancer Institute Grant Represents information pertaining to grant from National Institutes of Health and Business Innovation research for Lymphoma. National Institutes of Health Small Business Innovation Research For Lymphoma Grant [Member] SBIR lymphoma grant Award of money not required to be repaid for FDA grant. FDA Grant [Member] FDA grant Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. FINANCIAL CONDITION, GOING CONCERN AND MANAGEMENT PLANS [Line Items] LIQUIDITY AND FINANCIAL CONDITION Common Stock, Value, Subscriptions Aggregate offering price Represents the percent of calculation of compensation rate by using gross sales price per share sold. Common Stock, Shares, Commission Rate Calculation on Gross Sales Price per Share, Percent Commission rate Other Receivables Other receivables Funds received from grant Funds Received From Grant Funds received from grant Research and Development Arrangement, Contract to Perform for Others, Compensation Earned Amount of notice received Duration of grant assistance transaction, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Grant Assistance Term Grant Assistance Term Funds received from grant. Funds Received From CPRIT Grant Funds received from CPRIT grant Amount of grant income transfer product and service to customer for which consideration has been received or is receivable. Grant Received Grant income received Amount of receivable from Orphan Products Grant program. Orphan Products Grant Program Grant income receivable Revenue from grant related to CPRIT. Revenue From Grant Related to CPRIT Revenue from CPRIT The amount of cash held at financial institutions. Cash at Financial Institutions Cash at financial institutions US Government Agencies Securities, at Carrying Value Government agency securities Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] NET LOSS PER SHARE Net Income (Loss) Attributable to Parent, Diluted [Abstract] Numerator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Denominator: Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Warrant [Member] Common stock purchase warrants Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Potentially dilutive securities Schedule of Receivables with Imputed Interest [Table] Project [Axis] Project [Domain] The information pertaining to cancer Prevention And Research Institute Of Texas. Cancer Prevention And Research Institute Of Texas [Member] CPRIT Receivables with Imputed Interest [Line Items] OTHER RECEIVABLE Amount of revenue recognized for grant from Orphan Products Grant program. Revenue From Orphan Products Grant Program Grant revenue Fund received from grant Fund Received From Grant Funds received from grant Disposal Groups, Including Discontinued Operations [Table] Service [Member] Service Revenue This member stands for related party service. Related Party Service [Member] Related party service revenue Income Statement Location [Axis] Income Statement Location [Domain] Research and Development [Member] Research and development General and Administrative [Member] General and administrative Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] DISCONTINUED OPERATIONS Disposal Group, Including Discontinued Operation, Revenue Total revenues Disposal Group, Including Discontinued Operation, Operating Expense Total operating expenses Net Cash Provided by (Used in) Discontinued Operations Net increase (decrease) in cash and cash equivalents Related Party [Member] Related party Represents information pertaining to Clinical Trial Agreement with Wilson Wolf Manufacturing Corporation. Wilson Wolf Manufacturing Corporation [Member] Wilson Wolf Manufacturing Corporation Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax Gain on disposal of discontinued operations before income taxes Discontinued Operation, Tax Effect of Gain (Loss) from Disposal of Discontinued Operation Tax on gain on disposal of discontinued operations The amount of cash payment. Cash Payment Other Operating Income Agreement amount on cash payment The amount of additional revenue recognized. Additional Revenue Recognized Additional revenue recognized The amount of additional cash payment. Additional cash payment Additional cash payment This table lists the accounts payable and accrued liabilities. The line items identify information about the accounts payable and accrued liabilities. Accounts Payable And Accrued Liabilities [Table] Represents the information pertaining to Cell Ready. Cell Ready [Member] Cell Ready Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Accounts Payable And Accrued Liabilities [Line Items] ACCOUNTS PAYABLE, ACCRUED LIABILITIES AND RELATED PARTY PAYABLE Accounts Payable, Current Accounts payable Employee-related Liabilities, Current Compensation and benefits Accrued Professional Fees, Current Professional fees The amount of tax fees payable. Tax Fees Payable Tax fees Other Accrued Liabilities, Current Other Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. Accounts Payable and Accrued Liabilities Including Related party payable, Current Total accounts payable, accrued liabilities and related party payable Schedule of Stock by Class [Table] Sale of Stock [Axis] Sale of Stock [Domain] The member stands for ATM agreement. ATM Agreement [Member] ATM Agreement Class of Stock [Line Items] STOCKHOLDERS' EQUITY Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] This Member represents stock purchase agreement Stock Purchase Agreement [Member] Stock Purchase Agreement Subsidiary, Sale of Stock [Line Items] STOCKHOLDERS' EQUITY The time to time term to purchase shares in stock purchase agreement, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Stock Purchase Agreement, Time to Time Term to Purchase Shares Time to time term to purchase shares (in months) Represents the amount of commitment fees. Commitment Fee Commitment fee Option Indexed to Issuer's Equity, Type [Axis] Option Indexed to Issuer's Equity, Type [Domain] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Number of Shares Outstanding, Ending Balance Number of Shares Outstanding, Beginning Balance Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Number of Shares, Cancelled / Expired Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Number of Shares, Options vested and exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted Average Exercise Price per Share, Outstanding, Ending Balance Weighted Average Exercise Price per Share, Outstanding, Beginning Balance Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted Average Exercise Price per Share, Exercised Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Weighted Average Exercise Price per Share, Cancelled / Expired Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Weighted Average Exercise Price, Options vested and exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Total Intrinsic Value Outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Total Intrinsic Value, Options vested and exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Life, Outstanding (in years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Life, Options vested and exercisable (in years) Amount of expense for Stock compensation in continuing operations. Stock Compensation In Continuing Operations Stock compensation in continuing operations Amount of expense for Stock compensation in discontinued operations. Stock Compensation In Discontinued Operations Stock compensation in discontinued operations Allocated Share-based Compensation Expense Total stock compensation expenses Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period Number of equity incentive awards issued (in shares) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Total stock-based compensation cost related to unvested awards not yet recognized Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Expected weighted average period of recognition of unrecognized compensation costs (in years) This table lists the grant income. Grant Income [Table] Award of money not required to be repaid for CPRIT grant. CPRIT Grant [Member] CPRIT grant Line items represents grant income. Grant Income [Line Items] GRANT INCOME Receipt of product development research award Receipt Of Product Development Research Award Receipt of product development research award Restricted Cash Restricted cash recorded Grants Receivable Grant receivable Schedule of Related Party Transactions, by Related Party [Table] Represents information pertaining to Clinical Trial Agreement with Baylor College of Medicine. Clinical Trial Agreement with Baylor College of Medicine [Member] Baylor College of Medicine Related Party Transaction [Line Items] RELATED PARTY EXPENSES Related Party Transaction, Expenses from Transactions with Related Party Total Research and development Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization Service and manufacturing costs Invoices for the cost of product sold and service rendered, excluding depreciation, depletion, and amortization. Invoices Received for Services and Manufacturing Costs Paid invoices